SG129411A1 - New polysubstituted 1,1-pyridyloxycyclopropanaminecompounds, a process for their preparation and pharmaceutical compositions containing them - Google Patents
New polysubstituted 1,1-pyridyloxycyclopropanaminecompounds, a process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- SG129411A1 SG129411A1 SG200604914A SG200604914A SG129411A1 SG 129411 A1 SG129411 A1 SG 129411A1 SG 200604914 A SG200604914 A SG 200604914A SG 200604914 A SG200604914 A SG 200604914A SG 129411 A1 SG129411 A1 SG 129411A1
- Authority
- SG
- Singapore
- Prior art keywords
- pyridyloxycyclopropanaminecompounds
- preparation
- pharmaceutical compositions
- compositions containing
- new polysubstituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0508033A FR2889187B1 (fr) | 2005-07-28 | 2005-07-28 | Nouveaux composes 1,1-pyridinyloxycyclopropanamines polysusbstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG129411A1 true SG129411A1 (en) | 2007-02-26 |
Family
ID=35841768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200604914A SG129411A1 (en) | 2005-07-28 | 2006-07-21 | New polysubstituted 1,1-pyridyloxycyclopropanaminecompounds, a process for their preparation and pharmaceutical compositions containing them |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US7348344B2 (no) |
| EP (1) | EP1748043B1 (no) |
| JP (1) | JP2007077135A (no) |
| KR (1) | KR100824830B1 (no) |
| CN (1) | CN100519531C (no) |
| AR (1) | AR054875A1 (no) |
| AT (1) | ATE405550T1 (no) |
| AU (1) | AU2006203241A1 (no) |
| BR (1) | BRPI0603064A (no) |
| CA (1) | CA2552827A1 (no) |
| DE (1) | DE602006002328D1 (no) |
| DK (1) | DK1748043T3 (no) |
| EA (1) | EA011126B1 (no) |
| ES (1) | ES2313589T3 (no) |
| FR (1) | FR2889187B1 (no) |
| GE (1) | GEP20084548B (no) |
| HR (1) | HRP20080536T5 (no) |
| MA (1) | MA28426B1 (no) |
| MX (1) | MXPA06008415A (no) |
| NO (1) | NO20063461L (no) |
| NZ (1) | NZ548747A (no) |
| PL (1) | PL1748043T3 (no) |
| PT (1) | PT1748043E (no) |
| SG (1) | SG129411A1 (no) |
| SI (1) | SI1748043T1 (no) |
| WO (1) | WO2007012762A1 (no) |
| ZA (1) | ZA200606277B (no) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2896800B1 (fr) * | 2006-01-30 | 2008-04-11 | Servier Lab | Nouveaux composes pyridinylaminoalkylene-et pyridinyloxyalkylene-cyclopropanamines polysubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| DK2513085T3 (en) * | 2009-11-18 | 2016-12-05 | Suven Life Sciences Ltd | Alfa4beta2 bicyclic compounds as nicotinic acetylcholine receptor ligands |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2095350C1 (ru) * | 1993-10-13 | 1997-11-10 | Центр по химии лекарственных средств (ЦХЛС-ВНИХФИ) | 3-(n,n-диметилкарбамоилокси)-2-этил-6-метилпиридина сукцинат, обладающий антигипоксической активностью |
| TW544448B (en) * | 1997-07-11 | 2003-08-01 | Novartis Ag | Pyridine derivatives |
| FR2810664B1 (fr) * | 2000-06-27 | 2004-12-24 | Adir | Nouveaux composes cyclopropaniques 1,1 et 1,2-dissubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2005
- 2005-07-28 FR FR0508033A patent/FR2889187B1/fr not_active Expired - Fee Related
-
2006
- 2006-07-10 MA MA29177A patent/MA28426B1/fr unknown
- 2006-07-20 CA CA002552827A patent/CA2552827A1/fr not_active Abandoned
- 2006-07-21 SG SG200604914A patent/SG129411A1/en unknown
- 2006-07-26 MX MXPA06008415A patent/MXPA06008415A/es active IP Right Grant
- 2006-07-26 NZ NZ548747A patent/NZ548747A/en unknown
- 2006-07-26 US US11/493,070 patent/US7348344B2/en not_active Expired - Fee Related
- 2006-07-27 AT AT06291219T patent/ATE405550T1/de not_active IP Right Cessation
- 2006-07-27 NO NO20063461A patent/NO20063461L/no not_active Application Discontinuation
- 2006-07-27 SI SI200630083T patent/SI1748043T1/sl unknown
- 2006-07-27 PL PL06291219T patent/PL1748043T3/pl unknown
- 2006-07-27 GE GEAP20069543A patent/GEP20084548B/en unknown
- 2006-07-27 DE DE602006002328T patent/DE602006002328D1/de not_active Expired - Fee Related
- 2006-07-27 EA EA200601248A patent/EA011126B1/ru not_active IP Right Cessation
- 2006-07-27 EP EP06291219A patent/EP1748043B1/fr active Active
- 2006-07-27 KR KR1020060070569A patent/KR100824830B1/ko not_active IP Right Cessation
- 2006-07-27 DK DK06291219T patent/DK1748043T3/da active
- 2006-07-27 PT PT06291219T patent/PT1748043E/pt unknown
- 2006-07-27 ES ES06291219T patent/ES2313589T3/es active Active
- 2006-07-27 AR ARP060103249A patent/AR054875A1/es unknown
- 2006-07-27 WO PCT/FR2006/001832 patent/WO2007012762A1/fr active Application Filing
- 2006-07-28 BR BRPI0603064-5A patent/BRPI0603064A/pt not_active IP Right Cessation
- 2006-07-28 ZA ZA200606277A patent/ZA200606277B/xx unknown
- 2006-07-28 JP JP2006206041A patent/JP2007077135A/ja active Pending
- 2006-07-28 AU AU2006203241A patent/AU2006203241A1/en not_active Abandoned
- 2006-07-28 CN CNB2006101089323A patent/CN100519531C/zh not_active Expired - Fee Related
-
2008
- 2008-11-19 HR HR20080536T patent/HRP20080536T5/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20080536T5 (en) | 2009-03-31 |
| PL1748043T3 (pl) | 2008-12-31 |
| MXPA06008415A (es) | 2007-01-29 |
| ES2313589T3 (es) | 2009-03-01 |
| DK1748043T3 (da) | 2008-12-08 |
| PT1748043E (pt) | 2008-10-07 |
| JP2007077135A (ja) | 2007-03-29 |
| NZ548747A (en) | 2007-06-29 |
| AU2006203241A1 (en) | 2007-02-15 |
| NO20063461L (no) | 2007-01-29 |
| SI1748043T1 (sl) | 2008-12-31 |
| BRPI0603064A (pt) | 2007-08-14 |
| US20070027191A1 (en) | 2007-02-01 |
| CN1903843A (zh) | 2007-01-31 |
| FR2889187A1 (fr) | 2007-02-02 |
| CA2552827A1 (fr) | 2007-01-28 |
| EA200601248A1 (ru) | 2007-04-27 |
| EA011126B1 (ru) | 2008-12-30 |
| KR100824830B1 (ko) | 2008-04-23 |
| ZA200606277B (en) | 2007-04-25 |
| KR20070015011A (ko) | 2007-02-01 |
| EP1748043B1 (fr) | 2008-08-20 |
| HRP20080536T3 (en) | 2009-02-28 |
| MA28426B1 (fr) | 2007-02-01 |
| DE602006002328D1 (de) | 2008-10-02 |
| EP1748043A1 (fr) | 2007-01-31 |
| WO2007012762A1 (fr) | 2007-02-01 |
| CN100519531C (zh) | 2009-07-29 |
| GEP20084548B (en) | 2008-11-25 |
| AR054875A1 (es) | 2007-07-25 |
| FR2889187B1 (fr) | 2007-09-07 |
| US7348344B2 (en) | 2008-03-25 |
| ATE405550T1 (de) | 2008-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2384A (en) | 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| AP2303A (en) | d-Crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it. | |
| HUP0500170A2 (en) | Piperazine derivatives, process for producing them and pharmaceutical compositions containing them | |
| AP2006003521A0 (en) | Y-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it. | |
| IL189008A (en) | History of 1-Naphthalenyl-3-azabicyclo [0.1.3] hexane | |
| TWI315305B (en) | Piperidin-4-yl-amide derivatives,pharmaceutical compositions comprising the same,process for preparing the same and the use thereof | |
| HK1096386A1 (en) | Indanyl-piperazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HUP0401522A2 (en) | New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation | |
| IL186862A0 (en) | Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives | |
| SG121999A1 (en) | New benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
| ZA200902414B (en) | Indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
| HK1126190A1 (en) | Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them | |
| HK1096097A1 (en) | Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HK1093986A1 (en) | Piperazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
| SG129411A1 (en) | New polysubstituted 1,1-pyridyloxycyclopropanaminecompounds, a process for their preparation and pharmaceutical compositions containing them | |
| HK1098146A1 (en) | New polysubstituted 1,1-pyridylaminocyclopropanamine compounds, a process for their preparation and pharmaceutical compositions containing them | |
| ZA200902413B (en) | Novel indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
| ZA200501010B (en) | BenzoÄBÜchromeno-naphthyridin-7-one and pyranoÄ2'3':7,8ÜquinoÄ2,3-BÜquinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them. | |
| ZA200800833B (en) | New 1H-indole-pyridinecarboxamide and 1H-indolepiperidinecarboxamide compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HK1079775A1 (en) | New 4-oxo-4,6,7,8-tetrahydro-pyrrolo Ä1,2-AÜpyrazine-6-carboxamide compounds, a process for their preparation and pharmaceutical compositions containing them | |
| ZA200805656B (en) | Prodrug ER²-selective substances, methods for the production thereof and pharmaceutical compositions containing said compounds | |
| SG110170A1 (en) | New benzoindoline compounds, a process for their preparation and pharmaceutical compositions containing them | |
| SG122000A1 (en) | New benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them |